Literature DB >> 434931

Protective clothing as a means of reducing nicotine absorption in tobacco harvesters.

S H Gehlbach, W A Williams, J I Freeman.   

Abstract

Green tobacco sickness is an occupational illness of tobacco illness of tobacco harvesters that is thought to be caused by dermal absorption of nicotine from contact with green tobacco leaf. Wearing of rubberized nylon rainsuits effectively prevented nicotine absorption in volunteers who picked wet tobacco. Nicotine absorption was demonstrated in workers who wore clothing that was not waterproof.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434931     DOI: 10.1080/00039896.1979.10667379

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  7 in total

Review 1.  Green tobacco sickness.

Authors:  J S McBride; D G Altman; M Klein; W White
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

Review 2.  Green tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics.

Authors:  Lance R McMahon
Journal:  Expert Rev Clin Pharmacol       Date:  2019-01-24       Impact factor: 5.045

3.  Green tobacco sickness in children and adolescents.

Authors:  Robert H McKnight; Henry A Spiller
Journal:  Public Health Rep       Date:  2005 Nov-Dec       Impact factor: 2.792

4.  Predictors of incidence and prevalence of green tobacco sickness among Latino farmworkers in North Carolina, USA.

Authors:  T A Arcury; S A Quandt; J S Preisser
Journal:  J Epidemiol Community Health       Date:  2001-11       Impact factor: 3.710

Review 5.  Clinical pharmacokinetics of nicotine.

Authors:  C K Svensson
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

6.  Employee and customer handling of nicotine-containing e-liquids in vape shops.

Authors:  Robert Garcia; Jon Patrick Allem; Lourdes Baezconde-Garbanati; Jennifer Beth Unger; Steve Sussman
Journal:  Tob Prev Cessat       Date:  2017-01-20

Review 7.  Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group.

Authors:  Janet Chung-Hall; Lorraine Craig; Shannon Gravely; Natalie Sansone; Geoffrey T Fong
Journal:  Tob Control       Date:  2018-06-07       Impact factor: 7.552

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.